Search research articles
Contact Us
Filters
Showing results (301-310 of 347) with videos related to
Page
of 35
Sort By:
British Journal of Cancer
|
May 1, 1987
Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours
G Milano, M C Etienne, M Frenay, et al.
Biochemical and Biophysical Research Communications
|
April 25, 2000
Cloning and initial characterization of the human DPYD gene promoter
E S Collie-Duguid, S J Johnston, R H Powrie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2000
An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia
X Pivot, E Guardiola, M Etienne, et al.
International Journal of Cancer
|
April 18, 2001
Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival
C Rosty, M Chazal, M C Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2000
P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up
J M Ferrero, A Ramaioli, J L Formento, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 2001
The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy
N Magné, X Pivot, R J Bensadoun, et al.
Pathologie-Biologie
|
May 1, 1980
[Polyamines and malignant diseases (author's transl)]
G Milano, E Viguier, J P Cassuto, et al.
Journal of Pharmaceutical Sciences
|
December 1, 1991
Improved bioavailability of a new oral preparation of medroxyprogesterone acetate
M C Etienne, G Milano, N René, et al.
Oncology
|
October 5, 2011
A phase I study of UFT-oral vinorelbine in metastatic breast cancer
J M Ferrero, R Largillier, C Michel, et al.
Journal of Chemotherapy (Florence, Italy)
|
May 4, 2010
Erlotinib in combination with capecitabine (5'dFUR) in resistant pancreatic cancer cell lines
M Chefrour, J-L Fischel, P Formento, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 347) with videos related to
Sort By:
Page
of 35
British Journal of Cancer
|
May 1, 1987
Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours
G Milano, M C Etienne, M Frenay, et al.
Biochemical and Biophysical Research Communications
|
April 25, 2000
Cloning and initial characterization of the human DPYD gene promoter
E S Collie-Duguid, S J Johnston, R H Powrie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2000
An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia
X Pivot, E Guardiola, M Etienne, et al.
International Journal of Cancer
|
April 18, 2001
Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival
C Rosty, M Chazal, M C Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2000
P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up
J M Ferrero, A Ramaioli, J L Formento, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 2001
The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy
N Magné, X Pivot, R J Bensadoun, et al.
Pathologie-Biologie
|
May 1, 1980
[Polyamines and malignant diseases (author's transl)]
G Milano, E Viguier, J P Cassuto, et al.
Journal of Pharmaceutical Sciences
|
December 1, 1991
Improved bioavailability of a new oral preparation of medroxyprogesterone acetate
M C Etienne, G Milano, N René, et al.
Oncology
|
October 5, 2011
A phase I study of UFT-oral vinorelbine in metastatic breast cancer
J M Ferrero, R Largillier, C Michel, et al.
Journal of Chemotherapy (Florence, Italy)
|
May 4, 2010
Erlotinib in combination with capecitabine (5'dFUR) in resistant pancreatic cancer cell lines
M Chefrour, J-L Fischel, P Formento, et al.
Page
of 35